glp-1 pcos The dual impact of receptor agonists on metabolic and reproductive health in polycystic ovary syndrome: insights from human and animal trials Rising use of GLP-1 medications
Description
Eli Lillys decision to hike the UK list price of its weight-loss drug Mounjaro by as much as 170% isnt just about affordability
The databases used were Pubmed, Scopus and Cochrane
Metabolic disor...
The science, promise and clinical development of GLP-1 and GIP receptor agonists in obesity
